Nalu Medical, Inc.’s Post

Polling Q5/5 concludes this incredible 10-day #tutorial journey! What are the 4L treatment choices for ER+/HER2-low mBC patients? Join Dr. Aditya Bardia, one last time, for his response video, analyzing data on #ADCs including the noteworthy DESTINY-Breast04 & TROPICS-02 trials.  A heartfelt thanks to all for your active participation and for following along the hypothetical case of Amber for these 10-days! Special appreciation to Dr. Bardia for his invaluable collaboration. Clinical Takeaways:  1. Elacestrant increases PFS vs. SOC in ESR1m patients, irrespective of PIK3CAm or HER2-low status 2. Hyperglycemiais a target side effect of the PIK3CAi and needs to be monitored closely. 3. T-DXd can be considered in HER2-low mBC post ≥1 line of ChT

This is why patient organizations like CMTC-OVM exist. Beyond the medical aspects between patient and doctor, living with a (rare) condition not only impacts the patient and his own life but also the lives of parents, brothers, sisters, grandparents, neighbors and so on. Join CMTC-OVM. Meet other families at Family Day and get informed at the member conference in October. A (rare) condition is not something you have to face alone. Read more about our Cloverleaf model on our website: https://bit.ly/3AkwhsI @_allstripes, @CLOVESSyndrome, @deDuveInstitute, @EADV, @ECHAlliance, @EJPRareDiseases, @Eurordis, @findacure_fdn, @GoPI3Ks, @HuidNederland @IADPO, @Kidscape, @NevusN, @ORDIndia, @PatientWorthy, @rarebeacon, @rarediseaseuk, @RAREeCONNECT, @RareDiseases, @rarediseasesint, @RarediseasesSA, @RareDisorders, @RareShareOrg, @RareVoices, @Share4Rare, @SturgeWeber, @teaminspire, @vascern, @VBirthmarks, @VSOPzeldzaam #ERNeu, #EADV, #PROS, #VASCA, #VASCERN, #PIK3CA, #vascular, #VenousMalformations, #webinar, #KTS, #CLOVES, #DCMO, #ERN-Skin, #CMTC, #CMTCOVM, #DEDUVEINSTITUTE, #IADPO

Now Available on EDUCARE Platform 2 new IVUS clinical cases in Arterial, showcasing the potential of BSCI's portfolio in peripheral endovascular interventions. Performed at Clinique Rhéna in Strasbourg by Dr. Goyault, these cases offer over 1 hour of enriched learning, demonstrating diverse complexity levels of intervention. •Case 1 is a Symptomatic Fem-Pop Arterial Restenosis: Understand the comparison between IVUS and DSA for lesion assessment in symptomatic fem-pop arterial restenosis.  •Case 2 is a Complex Fem-pop Occlusion: Improve safety and early outcomes in complex fem-pop occlusion with the role of IVUS and atherectomy. Enhance your expertise with these insightful clinical cases here: https://lnkd.in/dj5ZbP-T #BSCEMEA #EDUCARE

Have you seen our NEW feature: 'Spotlight on: Prolonging #Remission In Patients With #AML'? 🗞️🩸 You'll learn more about: 🌟 Novel #transplant strategies, and reducing the risk of #relapse, Charlie Craddock 🌟 #VENTOGRAFT trial: AZA, VEN, and DLI in patients with #MDS and #AML who have relapsed following #alloSCT, Thomas Cluzeau 🌟 #Gilteritinib as post-#transplant maintenance therapy in #FLT3-ITD #AML, Mark Levis 🌟 Approaching patients with #MDS and #AML who relapse after #alloSCT & strategies to prevent #relapse, Pramila Krishnamurthy Take a look 👉 https://lnkd.in/eNm-pa2h #HemOnc #Leusm

Have you seen our NEW feature: 'Spotlight on: Prolonging #Remission In Patients With #AML'? 🗞️🩸 You'll learn more about: 🌟 Novel #transplant strategies, and reducing the risk of #relapse, Charlie Craddock 🌟 #VENTOGRAFT trial: AZA, VEN, and DLI in patients with #MDS and #AML who have relapsed following #alloSCT, Thomas Cluzeau 🌟 #Gilteritinib as post-#transplant maintenance therapy in #FLT3-ITD #AML, Mark Levis 🌟 Approaching patients with #MDS and #AML who relapse after #alloSCT & strategies to prevent #relapse, Pramila Krishnamurthy Take a look 👉 https://lnkd.in/eNm-pa2h #HemOnc #Leusm

This is why patient organizations like CMTC-OVM exist. Beyond the medical aspects between patient and doctor, living with a (rare) condition not only impacts the patient and his own life but also the lives of parents, brothers, sisters, grandparents, neighbors and so on. Join CMTC-OVM. Meet other families at Family Day and get informed at the member conference in October. A (rare) condition is not something you have to face alone. Read more about our Cloverleaf model on our website: https://bit.ly/3AkwhsI @_allstripes, @CLOVESSyndrome, @deDuveInstitute, @EADV, @ECHAlliance, @EJPRareDiseases, @Eurordis, @findacure_fdn, @GoPI3Ks, @HuidNederland @IADPO, @Kidscape, @NevusN, @ORDIndia, @PatientWorthy, @rarebeacon, @rarediseaseuk, @RAREeCONNECT, @RareDiseases, @rarediseasesint, @RarediseasesSA, @RareDisorders, @RareShareOrg, @RareVoices, @Share4Rare, @SturgeWeber, @teaminspire, @vascern, @VBirthmarks, @VSOPzeldzaam #ERNeu, #EADV, #PROS, #VASCA, #VASCERN, #PIK3CA, #vascular, #VenousMalformations, #webinar, #KTS, #CLOVES, #DCMO, #ERN-Skin, #CMTC, #CMTCOVM, #DEDUVEINSTITUTE, #IADPO

This is why patient organizations like CMTC-OVM exist. Beyond the medical aspects between patient and doctor, living with a (rare) condition not only impacts the patient and his own life but also the lives of parents, brothers, sisters, grandparents, neighbors and so on. Join CMTC-OVM. Meet other families at Family Day and get informed at the member conference in October. A (rare) condition is not something you have to face alone. Read more about our Cloverleaf model on our website: https://bit.ly/3AkwhsI @_allstripes, @CLOVESSyndrome, @deDuveInstitute, @EADV, @ECHAlliance, @EJPRareDiseases, @Eurordis, @findacure_fdn, @GoPI3Ks, @HuidNederland @IADPO, @Kidscape, @NevusN, @ORDIndia, @PatientWorthy, @rarebeacon, @rarediseaseuk, @RAREeCONNECT, @RareDiseases, @rarediseasesint, @RarediseasesSA, @RareDisorders, @RareShareOrg, @RareVoices, @Share4Rare, @SturgeWeber, @teaminspire, @vascern, @VBirthmarks, @VSOPzeldzaam #ERNeu, #EADV, #PROS, #VASCA, #VASCERN, #PIK3CA, #vascular, #VenousMalformations, #webinar, #KTS, #CLOVES, #DCMO, #ERN-Skin, #CMTC, #CMTCOVM, #DEDUVEINSTITUTE, #IADPO

Very powerful suction and distal reach

Are you attending AACR in San Diego this weekend? Diaceutics are here until Monday and we'd love to connect with you! If you have a precision medicine in your pipeline and have questions about your diagnostic landscape, let's chat. #AACR24 #PrecisionMedicine #PrecisionOncology

𝗗𝗲𝗲𝗽 𝗗𝗶𝘃𝗲𝘀 𝗶𝗻𝘁𝗼 𝗗𝗩𝗧: 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲𝗱 𝗕𝗠𝗝 𝗟𝗲𝗮𝗿𝗻𝗶𝗻𝗴 𝗠𝗼𝗱𝘂𝗹𝗲! Just finished the BMJ Learning module "Ask an Expert: Deep Vein Thrombosis" and feeling significantly more prepared to tackle this serious condition in primary care. This interactive module was a fantastic resource for GPs, providing crucial knowledge on diagnosing and managing DVT. Key takeaways empowering my patient care: Spotting the Signs: Learned how to effectively assess patients with suspected DVT based on symptoms. Wells Score Wisdom: Now confident in calculating the Wells score to guide diagnostic decision-making. Test Talk: Gained clarity on when to utilize Doppler ultrasound and D-dimer tests for optimal diagnosis. Treatment Timeliness: Equipped with the knowledge to initiate and manage anticoagulant therapy effectively. Referral Readiness: Feeling more comfortable identifying situations when referral for thrombophilia investigation is necessary. Big thanks to BMJ Learning for this informative module! I highly recommend it to fellow GPs looking to enhance their DVT management skills. #DVT #BMJLearning #primarycare #vascularhealth #CPD